- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY 1.51 Å
- Oligo State
- homo-24-mer
- Ligands
- 24 x BM0: 1-butyl-3-methyl-1H-imidazol-3-ium(Non-covalent)
- 96 x AU: GOLD ION(Non-covalent)
AU.2: 5 residues within 4Å:- Chain A: N.98, E.101, C.102
- Ligands: BM0.1, AU.4
Ligand excluded by PLIPAU.3: 6 residues within 4Å:- Chain A: C.90, W.93, N.98, C.102
- Ligands: AU.4, AU.5
Ligand excluded by PLIPAU.4: 5 residues within 4Å:- Chain A: W.93, C.102
- Ligands: BM0.1, AU.2, AU.3
Ligand excluded by PLIPAU.5: 3 residues within 4Å:- Chain A: D.89, C.90
- Ligands: AU.3
Ligand excluded by PLIPAU.7: 5 residues within 4Å:- Chain B: N.98, E.101, C.102
- Ligands: BM0.6, AU.9
Ligand excluded by PLIPAU.8: 6 residues within 4Å:- Chain B: C.90, W.93, N.98, C.102
- Ligands: AU.9, AU.10
Ligand excluded by PLIPAU.9: 5 residues within 4Å:- Chain B: W.93, C.102
- Ligands: BM0.6, AU.7, AU.8
Ligand excluded by PLIPAU.10: 3 residues within 4Å:- Chain B: D.89, C.90
- Ligands: AU.8
Ligand excluded by PLIPAU.12: 5 residues within 4Å:- Chain C: N.98, E.101, C.102
- Ligands: BM0.11, AU.14
Ligand excluded by PLIPAU.13: 6 residues within 4Å:- Chain C: C.90, W.93, N.98, C.102
- Ligands: AU.14, AU.15
Ligand excluded by PLIPAU.14: 5 residues within 4Å:- Chain C: W.93, C.102
- Ligands: BM0.11, AU.12, AU.13
Ligand excluded by PLIPAU.15: 3 residues within 4Å:- Chain C: D.89, C.90
- Ligands: AU.13
Ligand excluded by PLIPAU.17: 5 residues within 4Å:- Chain D: N.98, E.101, C.102
- Ligands: BM0.16, AU.19
Ligand excluded by PLIPAU.18: 6 residues within 4Å:- Chain D: C.90, W.93, N.98, C.102
- Ligands: AU.19, AU.20
Ligand excluded by PLIPAU.19: 5 residues within 4Å:- Chain D: W.93, C.102
- Ligands: BM0.16, AU.17, AU.18
Ligand excluded by PLIPAU.20: 3 residues within 4Å:- Chain D: D.89, C.90
- Ligands: AU.18
Ligand excluded by PLIPAU.22: 5 residues within 4Å:- Chain E: N.98, E.101, C.102
- Ligands: BM0.21, AU.24
Ligand excluded by PLIPAU.23: 6 residues within 4Å:- Chain E: C.90, W.93, N.98, C.102
- Ligands: AU.24, AU.25
Ligand excluded by PLIPAU.24: 5 residues within 4Å:- Chain E: W.93, C.102
- Ligands: BM0.21, AU.22, AU.23
Ligand excluded by PLIPAU.25: 3 residues within 4Å:- Chain E: D.89, C.90
- Ligands: AU.23
Ligand excluded by PLIPAU.27: 5 residues within 4Å:- Chain F: N.98, E.101, C.102
- Ligands: BM0.26, AU.29
Ligand excluded by PLIPAU.28: 6 residues within 4Å:- Chain F: C.90, W.93, N.98, C.102
- Ligands: AU.29, AU.30
Ligand excluded by PLIPAU.29: 5 residues within 4Å:- Chain F: W.93, C.102
- Ligands: BM0.26, AU.27, AU.28
Ligand excluded by PLIPAU.30: 3 residues within 4Å:- Chain F: D.89, C.90
- Ligands: AU.28
Ligand excluded by PLIPAU.32: 5 residues within 4Å:- Chain G: N.98, E.101, C.102
- Ligands: BM0.31, AU.34
Ligand excluded by PLIPAU.33: 6 residues within 4Å:- Chain G: C.90, W.93, N.98, C.102
- Ligands: AU.34, AU.35
Ligand excluded by PLIPAU.34: 5 residues within 4Å:- Chain G: W.93, C.102
- Ligands: BM0.31, AU.32, AU.33
Ligand excluded by PLIPAU.35: 3 residues within 4Å:- Chain G: D.89, C.90
- Ligands: AU.33
Ligand excluded by PLIPAU.37: 5 residues within 4Å:- Chain H: N.98, E.101, C.102
- Ligands: BM0.36, AU.39
Ligand excluded by PLIPAU.38: 6 residues within 4Å:- Chain H: C.90, W.93, N.98, C.102
- Ligands: AU.39, AU.40
Ligand excluded by PLIPAU.39: 5 residues within 4Å:- Chain H: W.93, C.102
- Ligands: BM0.36, AU.37, AU.38
Ligand excluded by PLIPAU.40: 3 residues within 4Å:- Chain H: D.89, C.90
- Ligands: AU.38
Ligand excluded by PLIPAU.42: 5 residues within 4Å:- Chain I: N.98, E.101, C.102
- Ligands: BM0.41, AU.44
Ligand excluded by PLIPAU.43: 6 residues within 4Å:- Chain I: C.90, W.93, N.98, C.102
- Ligands: AU.44, AU.45
Ligand excluded by PLIPAU.44: 5 residues within 4Å:- Chain I: W.93, C.102
- Ligands: BM0.41, AU.42, AU.43
Ligand excluded by PLIPAU.45: 3 residues within 4Å:- Chain I: D.89, C.90
- Ligands: AU.43
Ligand excluded by PLIPAU.47: 5 residues within 4Å:- Chain J: N.98, E.101, C.102
- Ligands: BM0.46, AU.49
Ligand excluded by PLIPAU.48: 6 residues within 4Å:- Chain J: C.90, W.93, N.98, C.102
- Ligands: AU.49, AU.50
Ligand excluded by PLIPAU.49: 5 residues within 4Å:- Chain J: W.93, C.102
- Ligands: BM0.46, AU.47, AU.48
Ligand excluded by PLIPAU.50: 3 residues within 4Å:- Chain J: D.89, C.90
- Ligands: AU.48
Ligand excluded by PLIPAU.52: 5 residues within 4Å:- Chain K: N.98, E.101, C.102
- Ligands: BM0.51, AU.54
Ligand excluded by PLIPAU.53: 6 residues within 4Å:- Chain K: C.90, W.93, N.98, C.102
- Ligands: AU.54, AU.55
Ligand excluded by PLIPAU.54: 5 residues within 4Å:- Chain K: W.93, C.102
- Ligands: BM0.51, AU.52, AU.53
Ligand excluded by PLIPAU.55: 3 residues within 4Å:- Chain K: D.89, C.90
- Ligands: AU.53
Ligand excluded by PLIPAU.57: 5 residues within 4Å:- Chain L: N.98, E.101, C.102
- Ligands: BM0.56, AU.59
Ligand excluded by PLIPAU.58: 6 residues within 4Å:- Chain L: C.90, W.93, N.98, C.102
- Ligands: AU.59, AU.60
Ligand excluded by PLIPAU.59: 5 residues within 4Å:- Chain L: W.93, C.102
- Ligands: BM0.56, AU.57, AU.58
Ligand excluded by PLIPAU.60: 3 residues within 4Å:- Chain L: D.89, C.90
- Ligands: AU.58
Ligand excluded by PLIPAU.62: 5 residues within 4Å:- Chain M: N.98, E.101, C.102
- Ligands: BM0.61, AU.64
Ligand excluded by PLIPAU.63: 6 residues within 4Å:- Chain M: C.90, W.93, N.98, C.102
- Ligands: AU.64, AU.65
Ligand excluded by PLIPAU.64: 5 residues within 4Å:- Chain M: W.93, C.102
- Ligands: BM0.61, AU.62, AU.63
Ligand excluded by PLIPAU.65: 3 residues within 4Å:- Chain M: D.89, C.90
- Ligands: AU.63
Ligand excluded by PLIPAU.67: 5 residues within 4Å:- Chain N: N.98, E.101, C.102
- Ligands: BM0.66, AU.69
Ligand excluded by PLIPAU.68: 6 residues within 4Å:- Chain N: C.90, W.93, N.98, C.102
- Ligands: AU.69, AU.70
Ligand excluded by PLIPAU.69: 5 residues within 4Å:- Chain N: W.93, C.102
- Ligands: BM0.66, AU.67, AU.68
Ligand excluded by PLIPAU.70: 3 residues within 4Å:- Chain N: D.89, C.90
- Ligands: AU.68
Ligand excluded by PLIPAU.72: 5 residues within 4Å:- Chain O: N.98, E.101, C.102
- Ligands: BM0.71, AU.74
Ligand excluded by PLIPAU.73: 6 residues within 4Å:- Chain O: C.90, W.93, N.98, C.102
- Ligands: AU.74, AU.75
Ligand excluded by PLIPAU.74: 5 residues within 4Å:- Chain O: W.93, C.102
- Ligands: BM0.71, AU.72, AU.73
Ligand excluded by PLIPAU.75: 3 residues within 4Å:- Chain O: D.89, C.90
- Ligands: AU.73
Ligand excluded by PLIPAU.77: 5 residues within 4Å:- Chain P: N.98, E.101, C.102
- Ligands: BM0.76, AU.79
Ligand excluded by PLIPAU.78: 6 residues within 4Å:- Chain P: C.90, W.93, N.98, C.102
- Ligands: AU.79, AU.80
Ligand excluded by PLIPAU.79: 5 residues within 4Å:- Chain P: W.93, C.102
- Ligands: BM0.76, AU.77, AU.78
Ligand excluded by PLIPAU.80: 3 residues within 4Å:- Chain P: D.89, C.90
- Ligands: AU.78
Ligand excluded by PLIPAU.82: 5 residues within 4Å:- Chain Q: N.98, E.101, C.102
- Ligands: BM0.81, AU.84
Ligand excluded by PLIPAU.83: 6 residues within 4Å:- Chain Q: C.90, W.93, N.98, C.102
- Ligands: AU.84, AU.85
Ligand excluded by PLIPAU.84: 5 residues within 4Å:- Chain Q: W.93, C.102
- Ligands: BM0.81, AU.82, AU.83
Ligand excluded by PLIPAU.85: 3 residues within 4Å:- Chain Q: D.89, C.90
- Ligands: AU.83
Ligand excluded by PLIPAU.87: 5 residues within 4Å:- Chain R: N.98, E.101, C.102
- Ligands: BM0.86, AU.89
Ligand excluded by PLIPAU.88: 6 residues within 4Å:- Chain R: C.90, W.93, N.98, C.102
- Ligands: AU.89, AU.90
Ligand excluded by PLIPAU.89: 5 residues within 4Å:- Chain R: W.93, C.102
- Ligands: BM0.86, AU.87, AU.88
Ligand excluded by PLIPAU.90: 3 residues within 4Å:- Chain R: D.89, C.90
- Ligands: AU.88
Ligand excluded by PLIPAU.92: 5 residues within 4Å:- Chain S: N.98, E.101, C.102
- Ligands: BM0.91, AU.94
Ligand excluded by PLIPAU.93: 6 residues within 4Å:- Chain S: C.90, W.93, N.98, C.102
- Ligands: AU.94, AU.95
Ligand excluded by PLIPAU.94: 5 residues within 4Å:- Chain S: W.93, C.102
- Ligands: BM0.91, AU.92, AU.93
Ligand excluded by PLIPAU.95: 3 residues within 4Å:- Chain S: D.89, C.90
- Ligands: AU.93
Ligand excluded by PLIPAU.97: 5 residues within 4Å:- Chain T: N.98, E.101, C.102
- Ligands: BM0.96, AU.99
Ligand excluded by PLIPAU.98: 6 residues within 4Å:- Chain T: C.90, W.93, N.98, C.102
- Ligands: AU.99, AU.100
Ligand excluded by PLIPAU.99: 5 residues within 4Å:- Chain T: W.93, C.102
- Ligands: BM0.96, AU.97, AU.98
Ligand excluded by PLIPAU.100: 3 residues within 4Å:- Chain T: D.89, C.90
- Ligands: AU.98
Ligand excluded by PLIPAU.102: 5 residues within 4Å:- Chain U: N.98, E.101, C.102
- Ligands: BM0.101, AU.104
Ligand excluded by PLIPAU.103: 6 residues within 4Å:- Chain U: C.90, W.93, N.98, C.102
- Ligands: AU.104, AU.105
Ligand excluded by PLIPAU.104: 5 residues within 4Å:- Chain U: W.93, C.102
- Ligands: BM0.101, AU.102, AU.103
Ligand excluded by PLIPAU.105: 3 residues within 4Å:- Chain U: D.89, C.90
- Ligands: AU.103
Ligand excluded by PLIPAU.107: 5 residues within 4Å:- Chain V: N.98, E.101, C.102
- Ligands: BM0.106, AU.109
Ligand excluded by PLIPAU.108: 6 residues within 4Å:- Chain V: C.90, W.93, N.98, C.102
- Ligands: AU.109, AU.110
Ligand excluded by PLIPAU.109: 5 residues within 4Å:- Chain V: W.93, C.102
- Ligands: BM0.106, AU.107, AU.108
Ligand excluded by PLIPAU.110: 3 residues within 4Å:- Chain V: D.89, C.90
- Ligands: AU.108
Ligand excluded by PLIPAU.112: 5 residues within 4Å:- Chain W: N.98, E.101, C.102
- Ligands: BM0.111, AU.114
Ligand excluded by PLIPAU.113: 6 residues within 4Å:- Chain W: C.90, W.93, N.98, C.102
- Ligands: AU.114, AU.115
Ligand excluded by PLIPAU.114: 5 residues within 4Å:- Chain W: W.93, C.102
- Ligands: BM0.111, AU.112, AU.113
Ligand excluded by PLIPAU.115: 3 residues within 4Å:- Chain W: D.89, C.90
- Ligands: AU.113
Ligand excluded by PLIPAU.117: 5 residues within 4Å:- Chain X: N.98, E.101, C.102
- Ligands: BM0.116, AU.119
Ligand excluded by PLIPAU.118: 6 residues within 4Å:- Chain X: C.90, W.93, N.98, C.102
- Ligands: AU.119, AU.120
Ligand excluded by PLIPAU.119: 5 residues within 4Å:- Chain X: W.93, C.102
- Ligands: BM0.116, AU.117, AU.118
Ligand excluded by PLIPAU.120: 3 residues within 4Å:- Chain X: D.89, C.90
- Ligands: AU.118
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Cosottini, L. et al., Structural Insight Into a Human H Ferritin@Gold-Monocarbene Adduct: Aurophilicity Revealed in a Biological Context. Angew.Chem.Int.Ed.Engl. (2025)
- Release Date
- 2025-05-07
- Peptides
- Ferritin heavy chain: ABCDEFGHIJKLMNOPQRSTUVWX
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
EF
FG
GH
HI
IJ
JK
KL
LM
MN
NO
OP
PQ
QR
RS
ST
TU
VV
WW
XX
Y
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY 1.51 Å
- Oligo State
- homo-24-mer
- Ligands
- 24 x BM0: 1-butyl-3-methyl-1H-imidazol-3-ium(Non-covalent)
- 96 x AU: GOLD ION(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Cosottini, L. et al., Structural Insight Into a Human H Ferritin@Gold-Monocarbene Adduct: Aurophilicity Revealed in a Biological Context. Angew.Chem.Int.Ed.Engl. (2025)
- Release Date
- 2025-05-07
- Peptides
- Ferritin heavy chain: ABCDEFGHIJKLMNOPQRSTUVWX
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
EF
FG
GH
HI
IJ
JK
KL
LM
MN
NO
OP
PQ
QR
RS
ST
TU
VV
WW
XX
Y